CardioDerm: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CardioDerm
Largest movements
- Cash -€396,237
down €396,237 (-71.6%), from €553,042 to €156,806
mainly Other debts (-€329,599) and Contributions, distributions and other (-€150,000)
- Receivables within one year -€12,107
down €12,107 (-68.1%), from €17,778 to €5,671
- Deferred charges and accrued income -€9,912
down €9,912 (-80.3%), from €12,343 to €2,430
- Other debts -€329,599
down €329,599 (-71.9%), from €458,682 to €129,083
- Tax, wage and social debts -€97,268
down €97,268 (-71.7%), from €135,600 to €38,331
- Profit (loss) carried forward +€8,443
up €8,443 (+29.0%), from €29,074 to €37,517
- Gross operating margin +€7,947
up €7,947 (+3.7%), from €214,372 to €222,318
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €639,589 | €218,972 | -€420,617 | -65.8% |
| Fixed assets | 21/28 | €56,426 | €54,065 | -€2,361 | -4.2% |
| Tangible fixed assets | 22/27 | €56,426 | €54,065 | -€2,361 | -4.2% |
| Other tangible fixed assets | 26 | €56,426 | €54,065 | -€2,361 | -4.2% |
| Current assets | 29/58 | €583,163 | €164,907 | -€418,256 | -71.7% |
| Amounts receivable within one year | 40/41 | €17,778 | €5,671 | -€12,107 | -68.1% |
| Trade receivables | 40 | €17,778 | €5,671 | -€12,107 | -68.1% |
| Cash at bank and in hand | 54/58 | €553,042 | €156,806 | -€396,237 | -71.6% |
| Deferred charges and accrued income | 490/1 | €12,343 | €2,430 | -€9,912 | -80.3% |
| Total equity and liabilities | 10/49 | €639,589 | €218,972 | -€420,617 | -65.8% |
| Equity | 10/15 | €34,074 | €42,517 | +€8,443 | +24.8% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €29,074 | €37,517 | +€8,443 | +29.0% |
| Amounts payable | 17/49 | €605,515 | €176,454 | -€429,060 | -70.9% |
| Amounts payable within one year | 42/48 | €602,491 | €173,017 | -€429,474 | -71.3% |
| Trade debts | 44 | €8,209 | €5,603 | -€2,606 | -31.7% |
| Suppliers | 440/4 | €8,209 | €5,603 | -€2,606 | -31.7% |
| Taxes, remuneration and social security | 45 | €135,600 | €38,331 | -€97,268 | -71.7% |
| Taxes | 450/3 | €135,600 | €38,331 | -€97,268 | -71.7% |
| Other amounts payable | 47/48 | €458,682 | €129,083 | -€329,599 | -71.9% |
| Accrued charges and deferred income | 492/3 | €3,024 | €3,438 | +€413 | +13.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €7,113 | €7,793 | +€680 | +9.6% |
| Other operating charges | 640/8 | €4,280 | €3,026 | -€1,255 | -29.3% |
| Gross operating margin | 9900 | €214,372 | €222,318 | +€7,947 | +3.7% |
| Operating profit (loss) | 9901 | €202,979 | €211,499 | +€8,521 | +4.2% |
| Financial charges | 65/66B | €113 | €116 | +€3 | +2.5% |
| Recurring financial charges | 65 | €113 | €116 | +€3 | +2.5% |
| Profit (loss) for the period before taxes | 9903 | €202,866 | €211,384 | +€8,518 | +4.2% |
| Income taxes | 67/77 | €51,077 | €52,941 | +€1,864 | +3.6% |
| Profit (loss) for the period | 9904 | €151,789 | €158,443 | +€6,654 | +4.4% |
| Profit (loss) for the period to be appropriated | 9905 | €151,789 | €158,443 | +€6,654 | +4.4% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 2 October 2026 via checked.be.